Facewall Intelligence has received a new round of financing of several hundred million yuan. Recently, Facewall Intelligence has completed a new round of financing of several hundred million yuan. This round of financing was jointly led by Loongson Venture Capital, Dinghui Baifu, Zhongguancun Science City Fund and Safran Investment Fund, and Beijing Artificial Intelligence Industry Investment Fund and Zero2IPO followed suit.The net outflow of the main market exceeded 10 billion.The President of Argentina announced that a package of financial, political and security reforms will be carried out next year. On December 10, local time, Argentine President Millai said in a televised speech on the first anniversary of his administration that a package of financial, political and security reforms will be carried out in 2025. Millay also announced that the national tax revenue will be reduced by 90%. (CCTV News)
South Korea's KOSPI index rose 1% to 2,442.31.Japan Life Insurance: Acquisition of American Resolution Life.Qianyuan Medicine established a research and development company in Shanghai. According to the enterprise search APP, Qianyuan Medicine Research and Development (Shanghai) Co., Ltd. was recently established, with Mao Rengang as the legal representative and a registered capital of 10 million yuan. Its business scope includes: medical research and experimental development; Technical service, technical development, technical consultation, technical exchange, technology transfer and technology popularization. Enterprise investigation shows that the company is wholly owned by Qianyuan Medicine.
The aquaculture sector oscillated to raise Huaying Agriculture's daily limit, the aquaculture sector oscillated to raise, Huaying Agriculture's daily limit, Tianyu Bio and Chuangye International's previous daily limit, and Zhongshui Fishery, Minhe Shares and Xiaoming Shares followed suit.How to "bargain" the price difference of Chinese patent medicines? According to CCTV news, the National Medical Insurance Bureau responded that the price of proprietary Chinese medicines is affected by many factors, including the price of medicinal materials, production technology and brand value, in view of the large price difference of proprietary Chinese medicines and the problem of "bargaining". Centralized purchasing effectively squeezes the inflated price of drugs and improves the efficiency of capital use through market-oriented bidding and price-volume linkage. At the same time, the medical insurance bureau will strengthen monitoring and supervision to ensure the quality and supply of drugs and protect the rights and interests of patients.Wei Shaojun, China Semiconductor Industry Association: We should vigorously develop chip design technology that does not depend on advanced technology. Wei Shaojun, chairman of the Integrated Circuit Design Branch of China Semiconductor Industry Association, said today that with the closure of chip design enterprises in China by external advanced processing resources, the manufacturing technologies that can be used by chip design enterprises in China are no longer as rich as before, and it is necessary to pay attention to the design technology that does not depend on advanced technology in technological innovation. Among them, there are two technical paths worth exploring. One is the innovation of architecture, which has been suggested by the industry that it is the golden age of computer architecture innovation. The second is micro-system integration, and the three-dimensional integration technology evolved from packaging technology is gradually moving towards the foreground. (Reporter Guo Hui)
Strategy guide 12-13
Strategy guide 12-13
Strategy guide 12-13
Strategy guide 12-13